InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,321.41
(
0.25%
)
US TECH 100
18,243.60
(
0.26%
)
Dow Jones
39,872.99
(
0.17%
)
Brent Oil
82.21
(
-0.29%
)
Bitcoin
69,898.48
(
-0.33%
)
Post# of 251888
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 195770

Thursday, 10/08/2015 11:20:07 AM

Thursday, October 08, 2015 11:20:07 AM

Post# of 251888
Opdivo-vs-Keytruda in advanced squamous NSCLC

RR was indeed impressive but as you noted only in the PD-L1-positive subgroup and docs will probably need a 2nd biopsy to define PD-L1 status among patients who had progressed. So currently my guess is Opdivo would do better in this indication.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up